140 related articles for article (PubMed ID: 35046363)
1. [Case of Unresectable Gastric Mixed Neuroendocrine Neoplasm(MiNEN)Treated with Chemotherapy].
Suemori K; Uno F; Hisamatsu K; Mizuno D; Miyauchi S; Iga N; Yoshida R; Kawai H; Ishizaki M; Nishi H
Gan To Kagaku Ryoho; 2022 Jan; 49(1):59-61. PubMed ID: 35046363
[TBL] [Abstract][Full Text] [Related]
2. [A case of mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) diagnosed by re-biopsy of the enlarged primary tumor during chemotherapy for gastric adenocarcinoma].
Fuchino M; Nakaya A; Ando T; Hasumoto Y; Ozawa K; Ito H; Yabushita K; Miwa S; Hayashi S
Nihon Shokakibyo Gakkai Zasshi; 2024; 121(1):55-62. PubMed ID: 38220181
[TBL] [Abstract][Full Text] [Related]
3. Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report.
Matsumoto R; Arigami T; Matsushita D; Okubo K; Tanaka T; Yanagita S; Sasaki K; Noda M; Kita Y; Mori S; Kurahara H; Ohtsuka T
World J Surg Oncol; 2020 Jul; 18(1):179. PubMed ID: 32693806
[TBL] [Abstract][Full Text] [Related]
4. [A Case of Lymph Nodes Metastases of Gastric Neuroendocrine Carcinoma Treated with Nivolumab and Showing Complete Response].
Wada N; Takachi K; Shirosaki Y; Fujiwara M; Fukuda N; Matsuura Y; Munakata K; Takiuchi D; Hama N; Ota H
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1546-1547. PubMed ID: 38303336
[TBL] [Abstract][Full Text] [Related]
5. [A Case of Unresectable Advanced Gastric Neuroendocrine Cell Carcinoma Treated with Nivolumab].
Yoshioka R; Nagase H; Noguchi K; Hamabe A; Hirota M; Oshima K; Tanida T; Ogino T; Tomimaru Y; Kawase T; Noura S; Imamura H; Iwasawa T; Akagi K; Ando H; Tamura H; Adachi S; Dono K
Gan To Kagaku Ryoho; 2018 Oct; 45(10):1530-1532. PubMed ID: 30382068
[TBL] [Abstract][Full Text] [Related]
6. Nivolumab exerts therapeutic effects against metastatic lesions from early gastric adenocarcinoma with a small proportion of neuroendocrine carcinoma after gastrectomy: a case report.
Sawayama H; Komohara Y; Hirao H; Sakata K; Takata N; Yoshinaka I; Harada K; Baba H
Clin J Gastroenterol; 2020 Oct; 13(5):759-765. PubMed ID: 32592148
[TBL] [Abstract][Full Text] [Related]
7. [A Case of Brain Metastasis of Gastric Cancer Successfully Treated with Nivolumab].
Omoto K; Urakami H; Seki S; Tanizawa S; Isobe Y
Gan To Kagaku Ryoho; 2021 May; 48(5):713-716. PubMed ID: 34006721
[TBL] [Abstract][Full Text] [Related]
8. [Brain Metastasis Arising from Gastric Cancer during Long-Term Treatment Using Nivolumab].
Namikawa T; Marui A; Yokota K; Kawanishi Y; Munekage M; Uemura S; Maeda H; Kitagawa H; Nagata Y; Kobayashi M; Hanazaki K
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1544-1546. PubMed ID: 36733129
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine Carcinoma of the Stomach: A Response to Combination Chemotherapy Consisting of Ramucirumab Plus Paclitaxel.
Matsubara Y; Ando T; Hosokawa A; Mihara H; Takagi H; Nakata N; Yoshita H; Nanjo S; Kajiura S; Fujinami H; Sugiyama T
Intern Med; 2018 Mar; 57(5):671-675. PubMed ID: 29151523
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of Nivolumab in a Case of Inoperable Advanced Gastric Cancer with Lung Metastasis].
Takahashi S; Hanaka J; Takahashi M; Okuda Y; Hara A; Yamanaka S; Nakamura Y; Kanamura S; Nakayama H; Goya T
Gan To Kagaku Ryoho; 2022 Nov; 49(11):1251-1253. PubMed ID: 36412030
[TBL] [Abstract][Full Text] [Related]
11. [A Case of Perforation of the Duodenum during Chemotherapy with Ramucirumab plus Nab-Paclitaxel for Advanced Gastric Cancer].
Hanayama H; Suzuki H; Mochizuki S; Hayashishita S; Matsuishi A; Kanouda R; Maruyama Y; Kaneta A; Kikuchi T; Nirei A; Tada T; Saze Z; Kono K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1636-1637. PubMed ID: 38303366
[TBL] [Abstract][Full Text] [Related]
12. [A Case of HER2 Positive Gastric Cancer That Was Highly Responsive to Fifth-Line Chemotherapy with Trastuzumab].
Sato H; Ii T; Hotchi S; Goh K; Rikiyama N; Sato A; Akishige N; Kokumai T; Aoki Y; Kikuchi D; Yamanami H
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1646-1648. PubMed ID: 35046284
[TBL] [Abstract][Full Text] [Related]
13. Successful Conversion Surgery for Advanced Gastric Cancer With Multiple Liver Metastases Following Ramucirumab Plus Paclitaxel Combination Treatment.
Namikawa T; Marui A; Yokota K; Fujieda Y; Munekage M; Uemura S; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
In Vivo; 2021; 35(5):2929-2935. PubMed ID: 34410989
[TBL] [Abstract][Full Text] [Related]
14. [A Case of Peritoneal Metastasis from an Unresectable Advanced Gastric Cancer with a Good Response to Nivolumab].
Kumano T; Shibata R; Ota A; Tanaka S; Komatsu S; Imura K; Shimomura K; Ikeda J; Taniguchi F; Shioaki Y
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2424-2426. PubMed ID: 33468982
[TBL] [Abstract][Full Text] [Related]
15. [A Case of Conversion Surgery after Nivolumab Monotherapy as Third-Line Therapy for Advanced Gastric Cancer].
Nishitani A; Noma T; Sakata K; Ikeda K; Miyazaki S
Gan To Kagaku Ryoho; 2023 Nov; 50(11):1199-1202. PubMed ID: 38056874
[TBL] [Abstract][Full Text] [Related]
16. [A Case of Advanced Gastric Cancer in Which Tumor Relapse Was Observed after Discontinuation of Nivolumab Due to Complete Response, and for Which Re-Administration Was Initiated].
Nishida K; Yagi H; Mizumoto R; Haeno M; Mori S; Nomura M; Yasuyama A; Yoshikawa Y; Sueda T; Matsumura T; Koga C; Miyagaki H; Tei M; Tsujie M; Akamaru Y
Gan To Kagaku Ryoho; 2023 Mar; 50(3):343-345. PubMed ID: 36927904
[TBL] [Abstract][Full Text] [Related]
17. [A Case of Non-Resectable Advanced Gastric Cancer for Which Nivolumab Was Markedly Effective].
Hanaka J; Hashimoto S; Takahashi S; Okuda Y; Kanamura S; Hara A; Kyoku K; Akiyama K; Takahashi M; Goya T
Gan To Kagaku Ryoho; 2021 Sep; 48(9):1165-1167. PubMed ID: 34521797
[TBL] [Abstract][Full Text] [Related]
18. [Hyperprogressive Disease during Treatment with Nivolumab for Recurrence of Gastric Cancer].
Takeoka T; Okada K; Matsuno H; Konishi K; Ota H; Yokoyama S; Fukunaga M; Kobayashi K
Gan To Kagaku Ryoho; 2020 Jan; 47(1):165-167. PubMed ID: 32381893
[TBL] [Abstract][Full Text] [Related]
19. [A case of metastatic gastric cancer showing long-term control with nivolumab after pseudoprogression].
Okamoto T; Ueda S
Nihon Shokakibyo Gakkai Zasshi; 2021; 118(6):549-554. PubMed ID: 34108354
[TBL] [Abstract][Full Text] [Related]
20. [Long-Term Response of Nivolumab for Peritoneal Dissemination and Recurrent Liver Metastasis after Surgery for Perforated Gastric Cancer-A Case Report].
Kii S; Kuratani Y; Fujiyoshi S; Shimokuni T; Nishikawa M; Koike M; Takahashi M
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1859-1861. PubMed ID: 36733023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
